About: A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1999 (uk) article scientifique publié en 1999 (fr) im Mai 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1999 (ast) scientific article published on 01 May 1999 (en)
publication date	wds:Q77363627-C27EF4F4-D32C-48E9-B39A-C1728ACFBC46
publication date	1999-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q77363627-01A3AE35-6967-4C30-8E34-B7280ABB0154 wds:Q77363627-1E272DD1-BF09-4E0A-B172-C26A258E4C49 wds:Q77363627-58D14F4B-91A5-4211-960C-3C0E421AC7E7 wds:Q77363627-DC235408-DA58-49CC-A2E7-4512BA4EEC45 wds:Q77363627-E7FFBFC5-4B33-48DB-BDCE-C664EDB74D55
author name string	Delsol G Dastugue N Mariamé B Lamant L Pulford K
rdfs:label	A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation (en) A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (nl)
skos:prefLabel	A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation (en) A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (nl)
name	A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation (en) A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (nl)
title	wds:Q77363627-3DA8A4B6-B7CF-4BFA-A741-7F591EE3C298
title	A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation (en)
page(s)	wds:Q77363627-D4F3C318-374B-440E-8716-B315AC741ED2
page(s)	3088-3095
instance of	wds:Q77363627-26D11B86-3486-474F-8C67-25920606AEE7
instance of	scholarly article
PubMed ID	wds:Q77363627-7E55BF54-4018-4495-BD1A-A59475232734
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10216106
PubMed ID	10216106
published in	wds:Q77363627-E75C5F53-2BFB-4A9B-AA13-B4758C448EC9
published in	Blood
issue	wds:Q77363627-EDCEA075-37EA-4A99-8EF5-FCE8AA7AB90F
volume	wds:Q77363627-9CA6FC2B-A9A8-4804-865B-A4E3569189A0
issue	9
volume	93
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77363627
is cites work of	TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. Anaplastic lymphoma kinase: signalling in development and disease Translocations in epithelial cancers Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination Fusion genes and their discovery using high throughput sequencing Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators Actin binding proteins: their ups and downs in metastatic life. Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage Novel ALK inhibitors in clinical use and development. Clinical relevance of molecular genetics to paediatric sarcomas Molecular genetics of pediatric soft tissue tumors: clinical application Molecular targets in therapy for human soft-tissue and bone sarcomas Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine. Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library Kinase fusions are frequent in Spitz tumours and spitzoid melanomas ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management ALK gene amplification is associated with poor prognosis in colorectal carcinoma NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases. Soft tissue tumors associated with EWSR1 translocation. ALK: a tyrosine kinase target for cancer therapy Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children Targeting ALK: Precision Medicine Takes on Drug Resistance Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms The role of molecular pathology in non-small-cell lung carcinoma-now and in the future Tyrosine phosphorylation in human lymphomas. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene. Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL). Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma Ligand-independent dimerization of ALK fusions Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes. The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC). Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review). ALK-immunoreactive neoplasms. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. Brentuximab vedotin: clinical updates and practical guidance. Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion Novel mRNA-containing cytoplasmic granules in ALK-transformed cells

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 173 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software